These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2408800)

  • 1. Interferon deficiency syndrome.
    Levin S; Hahn T
    Clin Exp Immunol; 1985 May; 60(2):267-73. PubMed ID: 2408800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of life-threatening viral infections with interferon alpha: pharmacokinetic studies in a clinical trial.
    Levin S; Hahn T; Rosenberg H; Bino T
    Isr J Med Sci; 1982 Apr; 18(4):439-46. PubMed ID: 6177663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the human interferon system in viral disease.
    Levin S; Hahn T
    Clin Exp Immunol; 1981 Dec; 46(3):475-83. PubMed ID: 6175461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon treatment in acute progressive and fulminant hepatitis.
    Levin S; Leibowitz E; Torten J; Hahn T
    Isr J Med Sci; 1989 Jul; 25(7):364-72. PubMed ID: 2474521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production.
    Andrade RM; Lima PG; Filho RG; Hygino J; Milczanowski SF; Andrade AF; Lauria C; Brindeiro R; Tanuri A; Bento CA
    AIDS; 2007 Aug; 21(13):1763-70. PubMed ID: 17690575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy.
    Okuse C; Rinaudo JA; Farrar K; Wells F; Korba BE
    Antiviral Res; 2005 Jan; 65(1):23-34. PubMed ID: 15652968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
    Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
    Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility to virus infection is determined by a Stat-mediated response to the autocrine effect of virus-induced type I interferon.
    Improta T; Pine R
    Cytokine; 1997 Jun; 9(6):383-93. PubMed ID: 9199872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha interferon production in patients with hairy cell leukemia: correlations with disease activity and remission status.
    Lepe-Zuniga JL; Quesada JR; Baron S; Reuben J; Gutterman JU
    Hematol Pathol; 1987; 1(3):157-65. PubMed ID: 3150846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mannoprotein-induced anti-U937 cell cytotoxicity in peripheral blood mononuclear cells from uninfected or HIV-infected subjects: role of interferon-gamma and tumor necrosis factor-alpha.
    Gomez MJ; Torosantucci A; Quinti I; Testa U; Peschle C; Cassone A
    Cell Immunol; 1993 Dec; 152(2):530-43. PubMed ID: 8258154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficient interferon-alpha response of newborns in comparison to adults.
    Neustock P; Kruse A; Bock S; St Pierre B; Kirchner H
    Lymphokine Cytokine Res; 1993 Apr; 12(2):109-14. PubMed ID: 8391859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon system in patients with systemic juvenile chronic arthritis: in vivo and in vitro studies.
    Bacon TH; de Vere-Tyndall A; Tyrrell DA; Denman AM; Ansell BM
    Clin Exp Immunol; 1983 Oct; 54(1):23-30. PubMed ID: 6413108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of lymphomonocyte activation by HIV-1 glycoprotein gp120. Possible role in AIDS pathogenesis.
    Capobianchi MR
    J Biol Regul Homeost Agents; 1996; 10(4):83-91. PubMed ID: 9604776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.
    Alvarado Esquivel C; Elewaut A; Philippé J; Elewaut AE; Desombere I; Maertens G; Leroux-Roels G
    Rev Invest Clin; 2002; 54(1):41-50. PubMed ID: 11995406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The capacity of blood lymphoid cells to produce alpha- and gamma-interferon is decreased during alpha-interferon therapy.
    Einhorn S; Ling P; Einhorn N; Strander H
    J Clin Lab Immunol; 1987 May; 23(1):35-8. PubMed ID: 3112404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiency of interferon-gamma but not interferon-beta in Arabian foals with severe combined immunodeficiency.
    Yilma T; Perryman LE; McGuire TC
    J Immunol; 1982 Sep; 129(3):931-3. PubMed ID: 6180003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of IFN-alpha, IFN-gamma, MxA, and IFN regulatory factor 1 genes in influenza A virus-infected human peripheral blood mononuclear cells.
    Ronni T; Sareneva T; Pirhonen J; Julkunen I
    J Immunol; 1995 Mar; 154(6):2764-74. PubMed ID: 7876547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-gamma (IFN-gamma).
    Itoh K; Shiiba K; Shimizu Y; Suzuki R; Kumagai K
    J Immunol; 1985 May; 134(5):3124-9. PubMed ID: 2984283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.